Cargando…
Partial Solvation Parameters of Drugs as a New Thermodynamic Tool for Pharmaceutics
Partial solvation parameters (PSP) have much in common with the Hansen solubility parameter or with a linear solvation energy relationship (LSER), but there are advantages based on the sound thermodynamic basis. It is, therefore, surprising that PSP has so far not been harnessed in pharmaceutics for...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6359455/ https://www.ncbi.nlm.nih.gov/pubmed/30621192 http://dx.doi.org/10.3390/pharmaceutics11010017 |
_version_ | 1783392256188743680 |
---|---|
author | Niederquell, Andreas Wyttenbach, Nicole Kuentz, Martin Panayiotou, Costas |
author_facet | Niederquell, Andreas Wyttenbach, Nicole Kuentz, Martin Panayiotou, Costas |
author_sort | Niederquell, Andreas |
collection | PubMed |
description | Partial solvation parameters (PSP) have much in common with the Hansen solubility parameter or with a linear solvation energy relationship (LSER), but there are advantages based on the sound thermodynamic basis. It is, therefore, surprising that PSP has so far not been harnessed in pharmaceutics for the selection of excipients or property estimation of formulations and their components. This work introduces PSP calculation for drugs, where the raw data were obtained from inverse gas chromatography. It was shown that only a few probe gases were needed to get reasonable estimates of the drug PSPs. Interestingly, an alternative calculation of LSER parameters in silico did not reflect the experimentally obtained activity coefficients for all probe gases as well, which was attributed to the complexity of the drug structures. The experimental PSPs were proven to be helpful in predicting drug solubility in various solvents and the PSP framework allowed calculation of the different surface energy contributions. A specific benefit of PSP is that parameters can be readily converted to either classical solubility or LSER parameters. Therefore, PSP is not just about a new definition of solvatochromic parameters, but the underlying thermodynamics provides a unified approach, which holds much promise for broad applications in pharmaceutics. |
format | Online Article Text |
id | pubmed-6359455 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-63594552019-02-14 Partial Solvation Parameters of Drugs as a New Thermodynamic Tool for Pharmaceutics Niederquell, Andreas Wyttenbach, Nicole Kuentz, Martin Panayiotou, Costas Pharmaceutics Article Partial solvation parameters (PSP) have much in common with the Hansen solubility parameter or with a linear solvation energy relationship (LSER), but there are advantages based on the sound thermodynamic basis. It is, therefore, surprising that PSP has so far not been harnessed in pharmaceutics for the selection of excipients or property estimation of formulations and their components. This work introduces PSP calculation for drugs, where the raw data were obtained from inverse gas chromatography. It was shown that only a few probe gases were needed to get reasonable estimates of the drug PSPs. Interestingly, an alternative calculation of LSER parameters in silico did not reflect the experimentally obtained activity coefficients for all probe gases as well, which was attributed to the complexity of the drug structures. The experimental PSPs were proven to be helpful in predicting drug solubility in various solvents and the PSP framework allowed calculation of the different surface energy contributions. A specific benefit of PSP is that parameters can be readily converted to either classical solubility or LSER parameters. Therefore, PSP is not just about a new definition of solvatochromic parameters, but the underlying thermodynamics provides a unified approach, which holds much promise for broad applications in pharmaceutics. MDPI 2019-01-04 /pmc/articles/PMC6359455/ /pubmed/30621192 http://dx.doi.org/10.3390/pharmaceutics11010017 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Niederquell, Andreas Wyttenbach, Nicole Kuentz, Martin Panayiotou, Costas Partial Solvation Parameters of Drugs as a New Thermodynamic Tool for Pharmaceutics |
title | Partial Solvation Parameters of Drugs as a New Thermodynamic Tool for Pharmaceutics |
title_full | Partial Solvation Parameters of Drugs as a New Thermodynamic Tool for Pharmaceutics |
title_fullStr | Partial Solvation Parameters of Drugs as a New Thermodynamic Tool for Pharmaceutics |
title_full_unstemmed | Partial Solvation Parameters of Drugs as a New Thermodynamic Tool for Pharmaceutics |
title_short | Partial Solvation Parameters of Drugs as a New Thermodynamic Tool for Pharmaceutics |
title_sort | partial solvation parameters of drugs as a new thermodynamic tool for pharmaceutics |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6359455/ https://www.ncbi.nlm.nih.gov/pubmed/30621192 http://dx.doi.org/10.3390/pharmaceutics11010017 |
work_keys_str_mv | AT niederquellandreas partialsolvationparametersofdrugsasanewthermodynamictoolforpharmaceutics AT wyttenbachnicole partialsolvationparametersofdrugsasanewthermodynamictoolforpharmaceutics AT kuentzmartin partialsolvationparametersofdrugsasanewthermodynamictoolforpharmaceutics AT panayiotoucostas partialsolvationparametersofdrugsasanewthermodynamictoolforpharmaceutics |